Yüklüyor......
A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity
Curative cancer therapies are uncommon and nearly always involve multi-drug combinations developed by experimentation in humans; unfortunately, the mechanistic basis for the success of such combinations has rarely been investigated in detail, obscuring lessons learned. Here, we use isobologram analy...
Kaydedildi:
| Yayımlandı: | eLife |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
eLife Sciences Publications, Ltd
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897534/ https://ncbi.nlm.nih.gov/pubmed/31742555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.50036 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|